BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2016
View Archived Issues
Novel S1P1 and S1P5 selective agonists identified for the treatment of autoimmune disease
Read More
Suven presents potent and selective H3R ligands with cognition-enhancing potential
Read More
DUOC-01 cells accelerate brain remyelination in vivo
Read More
Basilea Pharmaceutica patents MAPK inhibitors
Read More
F. Hoffmann-La Roche discloses HBsAg inhibitors
Read More
Chiesi develops compounds with mAChR antagonistic and beta2-adrenoceptor agonist activity
Read More
Merck Patent describes IRAK inhibitors
Read More
AbbVie reports SUV420H1 inhibitors
Read More
Early AR-101 immunotherapy is safe and effective in peanut-allergic preschool children
Read More
Researchers aim to find therapies for patients with hard-to-treat lymphomas
Read More
FDA gives favorable feedback to Corium's pre-IND application for Corplex memantine
Read More
FDA grants orphan drug designation to TG Therapeutics' TGR-1202
Read More
Ardelyx identifies promising gut-restricted TGR5 agonists
Read More
Insys Therapeutics reports positive results in phase III trial of buprenorphine sublingual spray
Read More
Abcellera Biologics completes antibody discovery partnership with Kodiak Sciences
Read More
Amgen receives FDA complete response letter for Parsabiv
Read More
Nymox Pharmaceutical announces positive results on fexapotide phase III trial
Read More
Mallinckrodt to sell its nuclear imaging business to IBA Molecular
Read More
Biothera expands collaboration with Merck & Co. for Keytruda combination study
Read More
FDA grants orphan drug designation to Scynexis' SCY-078 antifungal agent
Read More
FDA grants orphan drug designation to SFX-01 for the treatment of subarachnoid haemorrhage
Read More
Immix Biopharma completes stability testing for Imx-110
Read More